AbbVie Profile

USD 2.76  2.89%

Sale by Richard Gonzalez of 6200 shares of AbbVie

AbbVie insider trading alert for sale of common stock $0.01 par value by Richard Gonzalez, Chairman of the Board and CEO, on September 4, 2018. This event was filed by Abbvie Inc with SEC on 2017-08-08. Statement of changes in beneficial ownership - SEC Form 4. Richard Gonzalez is currently serves as chairman, ceo and chairman of executive committee of AbbVie [view details]   

AbbVie Summary

AbbVie (ABBV) is traded on BATS Exchange in USA. It is located in ILLINOIS U.S.A and employs 30,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 145.14 B. AbbVie conducts business under Healthcare sector and is part of Drug Manufacturers - Major industry. This company has 1.51 B outstanding shares of which 32.58 M shares are presently shorted by private and institutional investors with about 4.5 trading days to cover. AbbVie Inc. Commo currently holds about 3.74 B in cash with 9.33 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.47.
Check AbbVie Probability Of Bankruptcy

Ownership Allocation (%)

AbbVie Target Price Odds Analysis

Odds Below 92.61HorizonTargetOdds Above 92.61
1.82%30 days 92.61 98.11%
Based on normal probability distribution, the odds of AbbVie to move above current price in 30 days from now is about 98.0% (This AbbVie probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 30 days) .

AbbVie Top Holders

AbbVie Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Capital Research Global InvestorsCommon Shares193.8 M18 B
Vanguard Group IncCommon Shares117.8 M10.9 B
View AbbVie Diagnostics

AbbVie Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

AbbVie Key Fundamentals

AbbVie Against Markets

AbbVie Current Ratings

AbbVie 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for AbbVie are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 30000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
AbbVie SEC Filings
AbbVie SEC Filings
Security & Exchange Commission EDGAR ReportsView All
ChairmanRichard GonzalezView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
Business Address1 North Waukegan Road
Foreign Associates
ExchangeBATS Exchange
CIK Number0001551152
IndustryDrug Manufacturers - Major
Phone847 932 7900
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 15, 2018

Current Sentiment - ABBV

AbbVie Investor Sentiment

Majority of Macroaxis users are presently bullish on AbbVie. What is your sentiment towards investing in AbbVie? Are you bullish or bearish?
98% Bullish
2% Bearish

AbbVie Directors

AbbVie Corporate Directors

Frederick Waddell Independent Director
Robert Alpern Independent Director
Glenn Tilton Independent Director
Check also Trending Equities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.